Zealand Pharma A/S. Overview

Zealand Pharma A/S. Cost of Revenue

Cost of Revenue analysis for ZEAL.

Quarterly Cost of Revenue

$2.91M

As of Mar 10, 2022

Annual Cost of Revenue (TTM)

$93.05M

↑ 2.75% YoY

Trailing 12 months ending Mar 10, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin